Damir Vrabac is the Co-Founder & COO of Valar Labs, an artificial intelligence (AI) medtech/ healthtech/ digital pathology startup that analyzes cancer tissue samples and predicts which type of cancer treatment (surgery, radiation, chemotherapy, etc.) would be most successful for each individual cancer patient. Until now, this has been a very difficult thing for oncologists to predict. This incredible application of AI has the potential to have a life-saving impact on the lives of so many people. The Valar Labs founding team is out of Stanford. Their seed round was led by the venture capital firm Andreessen Horowitz (a16z).

Next Unicorn podcast episode 3. Also available on 🎙️Spotify, 🍎Apple Podcasts, or wherever else you get your podcasts.

Follow Damir Vrabac:
👥LinkedIn: [ Ссылка ]
🐦Twitter: [ Ссылка ]
💻Valar Labs: [ Ссылка ]

Follow Sasha Earnheart-Gold:
👥LinkedIn: [ Ссылка ]
🐦Twitter: [ Ссылка ]
📬Subscribe to the Next Unicorn email newsletter on Substack: [ Ссылка ]
💻website: [ Ссылка ]

Video Contents:
0:00 Teaser
1:14 Introduction
3:02 About Valar Labs: AI for treating cancer
40:09 Damir's personal career journey
52:55 Damir's startup learnings & advice for founders
1:04:43 Silicon Valley vs. Stockholm startup ecosystems
1:13:15 What is it like to be a foreigner startup founder in Silicon Valley?
1:16:17 Is it valuable to go through a startup accelerator program?
1:19:18 When should founders join a startup accelerator program?
1:21:34 Bonus Round

Credits:
Video/audio editor and engineer – Oleksii Kyrkach

свернуть